Your browser doesn't support javascript.
loading
Potent transmission-blocking monoclonal antibodies from naturally exposed individuals target a conserved epitope on Plasmodium falciparum Pfs230.
Ivanochko, Danton; Fabra-García, Amanda; Teelen, Karina; van de Vegte-Bolmer, Marga; van Gemert, Geert-Jan; Newton, Jocelyn; Semesi, Anthony; de Bruijni, Marloes; Bolscher, Judith; Ramjith, Jordache; Szabat, Marta; Vogt, Stefanie; Kraft, Lucas; Duncan, Sherie; Lee, Shwu-Maan; Kamya, Moses R; Feeney, Margaret E; Jagannathan, Prasanna; Greenhouse, Bryan; Sauerwein, Robert W; Richter King, C; MacGill, Randall S; Bousema, Teun; Jore, Matthijs M; Julien, Jean-Philippe.
Afiliação
  • Ivanochko D; Program in Molecular Medicine, the Hospital for Sick Children Research Institute, Toronto, ON, Canada.
  • Fabra-García A; Department of Medical Microbiology, Radboudumc, Nijmegen, the Netherlands.
  • Teelen K; Department of Medical Microbiology, Radboudumc, Nijmegen, the Netherlands.
  • van de Vegte-Bolmer M; Department of Medical Microbiology, Radboudumc, Nijmegen, the Netherlands.
  • van Gemert GJ; Department of Medical Microbiology, Radboudumc, Nijmegen, the Netherlands.
  • Newton J; Program in Molecular Medicine, the Hospital for Sick Children Research Institute, Toronto, ON, Canada.
  • Semesi A; Program in Molecular Medicine, the Hospital for Sick Children Research Institute, Toronto, ON, Canada.
  • de Bruijni M; TropIQ Health Sciences, Nijmegen, the Netherlands.
  • Bolscher J; TropIQ Health Sciences, Nijmegen, the Netherlands.
  • Ramjith J; Radboud Institute for Health Sciences, Department for Health Evidence, Biostatistics Section, Radboudumc, Nijmegen, the Netherlands.
  • Szabat M; AbCellera Biologics Inc., Vancouver, BC, Canada.
  • Vogt S; AbCellera Biologics Inc., Vancouver, BC, Canada.
  • Kraft L; AbCellera Biologics Inc., Vancouver, BC, Canada.
  • Duncan S; AbCellera Biologics Inc., Vancouver, BC, Canada.
  • Lee SM; PATH's Malaria Vaccine Initiative, Washington, DC 20001, USA.
  • Kamya MR; Infectious Disease Research Collaboration, Kampala, Uganda.
  • Feeney ME; Department of Medicine, University of California, San Francisco, San Francisco, CA, USA; Department of Pediatrics, University of California, San Francisco, San Francisco, CA, USA.
  • Jagannathan P; Department of Microbiology and Immunology, Stanford University, Stanford, CA, USA.
  • Greenhouse B; Department of Medicine, University of California, San Francisco, San Francisco, CA, USA.
  • Sauerwein RW; TropIQ Health Sciences, Nijmegen, the Netherlands.
  • Richter King C; PATH's Malaria Vaccine Initiative, Washington, DC 20001, USA.
  • MacGill RS; PATH's Malaria Vaccine Initiative, Washington, DC 20001, USA.
  • Bousema T; Department of Medical Microbiology, Radboudumc, Nijmegen, the Netherlands. Electronic address: teun.bousema@radboudumc.nl.
  • Jore MM; Department of Medical Microbiology, Radboudumc, Nijmegen, the Netherlands. Electronic address: matthijs.jore@radboudumc.nl.
  • Julien JP; Program in Molecular Medicine, the Hospital for Sick Children Research Institute, Toronto, ON, Canada; Departments of Biochemistry and Immunology, University of Toronto, Toronto, ON, Canada. Electronic address: jean-philippe.julien@sickkids.ca.
Immunity ; 56(2): 420-432.e7, 2023 02 14.
Article em En | MEDLINE | ID: mdl-36792575
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Malária Falciparum / Vacinas Antimaláricas Limite: Animals / Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Malária Falciparum / Vacinas Antimaláricas Limite: Animals / Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article